Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches

Experimental Cell Research

Volumn 319, Issue 11, 2013, Pages 1626-1634

  Baer, Caroline ^a   Squadrito, Mario Leonardo ^a   Iruela Arispe, M Luisa ^a,b   De Palma, Michele ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Blood vessel; Exosome; Heterotypic cell interaction; Macrophage; Microvesicle; Monocyte

Indexed keywords

COLONY STIMULATING FACTOR 1; GELATINASE A; GELATINASE B; MACROPHAGE ELASTASE; MATRILYSIN; NEUROPILIN 1; WNT PROTEIN;

ANGIOGENESIS; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; EXOSOME; HUMAN; IN VIVO STUDY; MACROPHAGE; MICROENVIRONMENT; MONOCYTE; MYELOID PROGENITOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; REVIEW; RHOMBENCEPHALON; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE;

ANGIOGENESIS; BLOOD VESSEL; EXOSOME; HETEROTYPIC CELL INTERACTION; MACROPHAGE; MICROVESICLE; MONOCYTE;

ANIMALS; CELL COMMUNICATION; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; HUMANS; MACROPHAGES; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84879601600     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.03.026     Document Type: Review

References (72)

1. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
2. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 2011, 11:723-737.
3. Pollard J.W. Trophic macrophages in development and disease. Nat. Rev. Immunol. 2009, 9:259-270.
4. Nucera S., Biziato D., De Palma M. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int. J. Dev. Biol. 2011, 55:495-503.
5. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., Sorg C. Macrophages and angiogenesis. J. Leukoc. Biol. 1994, 55:410-422.
6. Potente M., Gerhardt H., Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011, 146:873-887.
7. Weis S.M., Cheresh D.A. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med. 2011, 17:1359-1370.
8. Polverini P.J., Cotran P.S., Gimbrone M.A., Unanue E.R. Activated macrophages induce vascular proliferation. Nature 1977, 269:804-806.
9. Squadrito M.L., De Palma M. Macrophage regulation of tumor angiogenesis: implications for cancer therapy. Mol. Aspects Med. 2011, 32:123-145.
10. Bergers G., Brekken R., McMahon G., Vu T.H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2000, 2:737-744.
11. Sierra J.R., Corso S., Caione L., Cepero V., Conrotto P., Cignetti A., Piacibello W., Kumanogoh A., Kikutani H., Comoglio P.M., Tamagnone L., Giordano S. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J. Exp. Med. 2008, 205:1673-1685.
12. Fantin A., Vieira J.M., Gestri G., Denti L., Schwarz Q., Prykhozhij S., Peri F., Wilson S.W., Ruhrberg C. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 2010, 116:829-840.
13. Lin E.Y., Li J.F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., Qian H., Xue X.N., Pollard J.W. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006, 66:11238-11246.
14. Lewis C.E., Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006, 66:605-612.
15. De Palma M., Venneri M.A., Roca C., Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 2003, 9:789-795.
16. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal R.G., Moore M.A., Hajjar K.A., Manova K., Benezra R., Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001, 7:1194-1201.
17. Leek R.D., Lewis C.E., Whitehouse R., Greenall M., Clarke J., Harris A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 1996, 56:4625-4629.
18. Leek R.D., Landers R.J., Harris A.L., Lewis C.E. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br. J. Cancer 1999, 79:991-995.
19. Giraudo E., Inoue M., Hanahan D. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J. Clin. Invest. 2004, 114:623-633.
20. De Palma M., Venneri M.A., Galli R., Sergi S.L., Politi L.S., Sampaolesi M., Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8:211-226.
21. Bingle L., Lewis C.E., Corke K.P., Reed M.W., Brown N.J. Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br. J. Cancer 2006, 94:101-107.
22. Zeisberger S.M., Odermatt B., Marty C., Zehnder-Fjallman A.H., Ballmer-Hofer K., Schwendener R.A. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer 2006, 95:272-281.
23. Tammela T., Zarkada G., Nurmi H., Jakobsson L., Heinolainen K., Tvorogov D., Zheng W., Franco C.A., Murtomaki A., Aranda E., Miura N., Yla-Herttuala S., Fruttiger M., Makinen T., Eichmann A., Pollard J.W., Gerhardt H., Alitalo K. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol. 2011, 13:1202-1213.
24. Murdoch C., Muthana M., Coffelt S.B., Lewis C.E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008, 8:618-631.
25. De Palma M., Coussens L.M. Immune cells and inflammatory mediators as regulators of tumor angiogenesis. Angiogenesis: An integrative Approach from Science to Medicine 2008, 225-238. Springer Science, New York. W. Figg, J. Folkman (Eds.).
26. Tamagnone L. Emerging role of semaphorins as major regulatory signals and potential therapeutic targets in cancer. Cancer Cell 2012, 22:145-152.
27. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2:569-579.
28. Simons M., Raposo G. Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 2009, 21:575-581.
29. Tondravi M.M., McKercher S.R., Anderson K., Erdmann J.M., Quiroz M., Maki R., Teitelbaum S.L. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 1997, 386:81-84.
30. Wiktor-Jedrzejczak W., Bartocci A., Ferrante A.W., Ahmed-Ansari A., Sell K.W., Pollard J.W., Stanley E.R. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 1990, 87:4828-4832.
31. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
32. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
33. Pucci F., Venneri M.A., Biziato D., Nonis A., Moi D., Sica A., Di S.C., Naldini L., Palma M. De A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood resident monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 2009, 114:901-914.
34. Fantin A., Vieira J.M., Plein A., Denti L., Fruttiger M., Pollard J.W., Ruhrberg C. NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. Blood 2013.
35. Kubota Y., Takubo K., Shimizu T., Ohno H., Kishi K., Shibuya M., Saya H., Suda T. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J. Exp. Med. 2009, 206:1089-1102.
36. Fruttiger M. Development of the retinal vasculature. Angiogenesis 2007, 10:77-88.
37. Stahl A., Connor K.M., Sapieha P., Chen J., Dennison R.J., Krah N.M., Seaward M.R., Willett K.L., Aderman C.M., Guerin K.I., Hua J., Lofqvist C., Hellstrom A., Smith L.E. The mouse retina as an angiogenesis model. Invest. Ophthalmol. Vis. Sci. 2010, 51:2813-2826.
38. Rymo S.F., Gerhardt H., Wolfhagen S.F., Lang R., Uv A., Betsholtz C. A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS. One 2011, 6:e15846.
39. Stefater J.A., Lewkowich I., Rao S., Mariggi G., Carpenter A.C., Burr A.R., Fan J., Ajima R., Molkentin J.D., Williams B.O., Wills-Karp M., Pollard J.W., Yamaguchi T., Ferrara N., Gerhardt H., Lang R.A. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 2011, 474:511-515.
40. Smalley M.J., Dale T.C. Wnt signalling in mammalian development and cancer. Cancer Metastasis Rev. 1999, 18:215-230.
41. Eubank T.D., Roberts R., Galloway M., Wang Y., Cohn D.E., Marsh C.B. GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice. Immunity 2004, 21:831-842.
42. Saint-Geniez M., D'Amore P.A. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int. J. Dev. Biol. 2004, 48:1045-1058.
43. Lobov I.B., Rao S., Carroll T.J., Vallance J.E., Ito M., Ondr J.K., Kurup S., Glass D.A., Patel M.S., Shu W., Morrisey E.E., McMahon A.P., Karsenty G., Lang R.A. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 2005, 437:417-421.
44. Rao S., Lobov I.B., Vallance J.E., Tsujikawa K., Shiojima I., Akunuru S., Walsh K., Benjamin L.E., Lang R.A. Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch. Development 2007, 134:4449-4458.
45. Checchin D., Sennlaub F., Levavasseur E., Leduc M., Chemtob S. Potential role of microglia in retinal blood vessel formation. Invest. Ophthalmol. Vis. Sci. 2006, 47:3595-3602.
46. Mazzieri R., Pucci F., Moi D., Zonari E., Ranghetti A., Berti A., Politi L.S., Gentner B., Brown J.L., Naldini L., De Palma M. Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 2011, 19:512-526.
47. Fiedler U., Scharpfenecker M., Koidl S., Hegen A., Grunow V., Schmidt J.M., Kriz W., Thurston G., Augustin H.G. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood 2004, 103:4150-4156.
48. De Palma M., Naldini L. Angiopoietin-2 TIEs up macrophages in tumor angiogenesis. Clin. Cancer Res. 2011, 17:5226-5232.
49. Holopainen T., Saharinen P., D'Amico G., Lampinen A., Eklund L., Sormunen R., Anisimov A., Zarkada G., Lohela M., Helotera H., Tammela T., Benjamin L.E., Yla-Herttuala S., Leow C.C., Koh G.Y., Alitalo K. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl. Cancer Inst. 2012, 104:461-475.
50. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Jung S., Chimenti S., Landsman L., Abramovitch R., Keshet E. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
51. Harvey N.L., Gordon E.J. Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis. Vasc. Cell 2012, 4:15.
52. Gordon E.J., Rao S., Pollard J.W., Nutt S.L., Lang R.A., Harvey N.L. Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation. Development 2010, 137:3899-3910.
53. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
54. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest 2012, 122:787-795.
55. Ojalvo L.S., King W., Cox D., Pollard J.W. High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am. J. Pathol. 2009, 174:1048-1064.
56. Gomez P.E., Schulz C., Geissmann F. Development and homeostasis of resident myeloid cells: the case of the microglia. Glia 2013, 61:112-120.
57. Clear A.J., Lee A.M., Calaminici M., Ramsay A.G., Morris K.J., Hallam S., Kelly G., Macdougall F., Lister T.A., Gribben J.G. Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment. Blood 2010, 115:5053-5056.
58. Matsubara T., Kanto T., Kuroda S., Yoshio S., Higashitani K., Kakita N., Miyazaki M., Sakakibara M., Hiramatsu N., Kasahara A., Tomimaru Y., Tomokuni A., Nagano H., Hayashi N., Takehara T. TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlated with angiogenesis. Hepatology 2012.
59. Lewis J.S., Landers R.J., Underwood J.C., Harris A.L., Lewis C.E. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol. 2000, 192:150-158.
60. He H., Xu J., Warren C.M., Duan D., Li X., Wu L., Iruela-Arispe M.L. Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages. Blood 2012, 120:3152-3162.
61. Squadrito M.L., Pucci F., Magri L., Moi D., Gilfillan G.D., Ranghetti A., Casazza A., Mazzone M., Lyle R., Naldini L., De Palma M. miR-511-3p modulates genetic programs of tumor-associated macrophages. Cell Rep 2012, 1:141-154.
62. De Palma M. Partners in crime: VEGF and IL-4 conscript tumour-promoting macrophages. J. Pathol. 2012, 227:4-7.
63. De Palma M., Mazzieri R., Politi L.S., Pucci F., Zonari E., Sitia G., Mazzoleni S., Moi D., Venneri M.A., Indraccolo S., Falini A., Guidotti L.G., Galli R., Naldini L. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. Cancer Cell 2008, 14:299-311.
64. Cortez-Retamozo V., Etzrodt M., Newton A., Rauch P.J., Chudnovskiy A., Berger C., Ryan R.J., Iwamoto Y., Marinelli B., Gorbatov R., Forghani R., Novobrantseva T.I., Koteliansky V., Figueiredo J.L., Chen J.W., Anderson D.G., Nahrendorf M., Swirski F.K., Weissleder R., Pittet M.J. Origins of tumor-associated macrophages and neutrophils. Proc. Natl. Acad. Sci. USA 2012, 109:2491-2496.
65. Jenkins S.J., Ruckerl D., Cook P.C., Jones L.H., Finkelman F.D., van R.N., MacDonald A.S., Allen J.E. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011, 332:1284-1288.
66. F. Pucci, M.J. Pittet, Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivo. Clin. Cancer Res. (2013). DOI:10.1158/1078-0432.CCR-12-0962.
67. Qu Y., Franchi L., Nunez G., Dubyak G.R. Nonclassical IL-1 beta secretion stimulated by P2×7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 2007, 179:1913-1925.
68. Johansson S.M., Admyre C., Scheynius A., Gabrielsson S. Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes. Immunology 2008, 123:491-499.
69. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., Sun F., Lu J., Yin Y., Cai X., Sun Q., Wang K., Ba Y., Wang Q., Wang D., Yang J., Liu P., Xu T., Yan Q., Zhang J., Zen K., Zhang C.Y. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 2010, 39:133-144.
70. Montecalvo A., Larregina A.T., Shufesky W.J., Stolz D.B., Sullivan M.L., Karlsson J.M., Baty C.J., Gibson G.A., Erdos G., Wang Z., Milosevic J., Tkacheva O.A., Divito S.J., Jordan R., Lyons-Weiler J., Watkins S.C., Morelli A.E. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012, 119:756-766.
71. Yang M., Chen J., Su F., Yu B., Su F., Lin L., Liu Y., Huang J.D., Song E. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 2011, 10:117.
72. Squadrito M.L., Etzrodt M., De Palma M., Pittet M.J. MicroRNA-mediated control of macrophages and its implications for cancer. Trends Immunol. 2013, doi:pii: S1471-4906(13)00029-X. 10.1016/j.it.2013.02.003.